Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.5 (
thrombin
)
33,306
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although signaling of
thrombin
via its receptor protease-activated receptor 1 (Par1) is known to occur in atherothrombosis, its link to the actual pathogenesis of this condition is less clear. To better understand the role of
thrombin
-Par1 signaling in atherosclerosis, here we have studied their effects on cellular cholesterol efflux in mice. We found that by activating Par1 and
cullin 3
-mediated ubiquitination and degradation of ABC subfamily A member 1 (ABCA1),
thrombin
inhibits cholesterol efflux in both murine macrophages and smooth muscle cells. Moreover, disruption of the
Par1
gene rescued ABCA1 from Western diet-induced ubiquitination and degradation and restored cholesterol efflux in apolipoprotein E-deficient (ApoE
-/-
) mice. Similarly, the
Par1
deletion diminished diet-induced atherosclerotic lesions in the ApoE
-/-
mice. These observations for the first time indicate a role for
thrombin
-Par1 signaling in the pathogenesis of diet-induced atherosclerosis. We identify
cullin 3
as a cullin-RING ubiquitin E3 ligase that mediates ABCA1 ubiquitination and degradation and thereby inhibits cholesterol efflux. Furthermore, compared with peripheral blood mononuclear cells (PBMCs) from ApoE
-/-
mice, the PBMCs from ApoE
-/-
:Par1
-/-
mice exhibited decreased trafficking to inflamed arteries of Western diet-fed ApoE
-/-
mice. This finding suggested that besides inhibiting cholesterol efflux,
thrombin
-Par1 signaling also plays a role in the recruitment of leukocytes during diet-induced atherogenesis. Based on these findings, we conclude that
thrombin
-Par1 signaling appears to contribute to the pathogenesis of atherosclerosis by impairing cholesterol efflux from cells and by recruiting leukocytes to arteries.
...
PMID:Protease-activated receptor 1 inhibits cholesterol efflux and promotes atherogenesis via cullin 3-mediated degradation of the ABCA1 transporter. 2977 60